These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32208781)

  • 1. Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity.
    Al-Rashood ST; Hamed AR; Hassan GS; Alkahtani HM; Almehizia AA; Alharbi A; Al-Sanea MM; Eldehna WM
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):831-839. PubMed ID: 32208781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fe
    Maddela S; Makula A; Galigniana MD; Parambi DGT; Federicci F; Mazaira G; Hendawy OM; Dev S; Mathew GE; Mathew B
    Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800174. PubMed ID: 30485473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma.
    Shaaban S; Ashmawy AM; Negm A; Wessjohann LA
    Eur J Med Chem; 2019 Oct; 179():515-526. PubMed ID: 31276896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.
    Islam MS; Ghawas HM; El-Senduny FF; Al-Majid AM; Elshaier YAMM; Badria FA; Barakat A
    Bioorg Chem; 2019 Feb; 82():423-430. PubMed ID: 30508794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators.
    Lotfy G; Abdel Aziz YM; Said MM; El Ashry ESH; El Tamany ESH; Abu-Serie MM; Teleb M; Dömling A; Barakat A
    Bioorg Chem; 2021 Dec; 117():105427. PubMed ID: 34794098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Scaffold Evaluation and Systems-Level Transcriptome-Based Analysis for Accelerated Lead Optimization Reveals Ribosomal Targeting Spirooxindole Cyclopropanes.
    Rodriguez KX; Howe EN; Bacher EP; Burnette M; Meloche JL; Meisel J; Schnepp P; Tan X; Chang M; Zartman J; Zhang S; Ashfeld BL
    ChemMedChem; 2019 Sep; 14(18):1653-1661. PubMed ID: 31140738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One Pot Synthesis and Biological Activity Studies of New Spirooxindoles.
    Omidvar AR; Asghari S; Ghasempour L; Mohseni M
    Chem Biodivers; 2024 Jun; 21(6):e202301942. PubMed ID: 38393713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents.
    Al-Majid AM; Ali M; Islam MS; Alshahrani S; Alamary AS; Yousuf S; Choudhary MI; Barakat A
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic effect of chromanone derivative, hyrtiosone A from marine demosponge Hyrtios erectus in hepatocellular carcinoma HepG2 cells.
    Chakraborty K; Francis P
    Bioorg Chem; 2021 Sep; 114():105119. PubMed ID: 34252861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
    Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Apoptosis by Nano-Synthesized Complexes of H2L and its Cu(II) Complex in Human Hepatocellular Carcinoma Cells.
    Diab T; Mohamed TM; Hamed A; Gaber M
    Anticancer Agents Med Chem; 2021; 21(9):1151-1159. PubMed ID: 32013853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
    Harras MF; Sabour R
    Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting the antiproliferative potential of spiropyrazoline oxindoles in a human ovarian cancer cell line.
    Raposo LR; Silva A; Silva D; Roma-Rodrigues C; Espadinha M; Baptista PV; Santos MMM; Fernandes AR
    Bioorg Med Chem; 2021 Jan; 30():115880. PubMed ID: 33348171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
    Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New spiroindolinones bearing 5-chlorobenzothiazole moiety.
    Ermut G; Karalı N; Özsoy N; Can A
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):457-68. PubMed ID: 23738950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, toxicity and antitumor activity of cobalt carbonyl complexes targeting hepatocellular carcinoma.
    Li J; Zhang J; Zhang Q; Wang Y; Bai Z; Zhao Q; He D; Wang Z; Zhang J; Chen Y
    Bioorg Med Chem; 2019 Oct; 27(20):115071. PubMed ID: 31472989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
    Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity.
    Chahal S; Rani P; Shweta ; Goel KK; Joshi G; Singh R; Kumar P; Singh D; Sindhu J
    Bioorg Chem; 2024 Jun; 147():107363. PubMed ID: 38657527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.
    Rana M; Arif R; Khan FI; Maurya V; Singh R; Faizan MI; Yasmeen S; Dar SH; Alam R; Sahu A; Ahmad T; Rahisuddin
    Bioorg Chem; 2021 Mar; 108():104665. PubMed ID: 33571809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
    Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
    Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.